8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Locally instructed CXCR4 hi neutrophils trigger environment-driven allergic asthma through the release of neutrophil extracellular traps

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Low exposure to microbial products, respiratory viral infections and air pollution is a major risk factor for allergic asthma, yet the mechanistic links between such conditions and host susceptibility to type 2 allergic disorders remain unclear. Through the use of single-cell RNA sequencing (scRNA-seq), we characterized lung neutrophils in mice exposed to a pro-allergic, low dose of lipopolysaccharides (LPS lo) or a protective, high dose of LPS (LPS hi) before exposure to house dust mite (HDM). Unlike exposure to LPS hi, exposure to LPS lo instructed recruited neutrophils to upregulate the expression of the chemokine receptor CXCR4 and to release neutrophil extracellular traps (NETs). The LPS lo-induced neutrophils and NETs potentiated the uptake of HDM by CD11b +Ly-6C + dendritic cells (DCs) and type 2 allergic airway inflammation in response to HDM. NETs derived from CXCR4 hi neutrophils were also needed to mediate allergic asthma triggered by infection with influenza virus or exposure to ozone. Our study indicates that apparently unrelated environmental risk factors can shape recruited lung neutrophils to promote the initiation of allergic asthma.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          The development of allergic inflammation.

          Allergic disorders, such as anaphylaxis, hay fever, eczema and asthma, now afflict roughly 25% of people in the developed world. In allergic subjects, persistent or repetitive exposure to allergens, which typically are intrinsically innocuous substances common in the environment, results in chronic allergic inflammation. This in turn produces long-term changes in the structure of the affected organs and substantial abnormalities in their function. It is therefore important to understand the characteristics and consequences of acute and chronic allergic inflammation, and in particular to explore how mast cells can contribute to several features of this maladaptive pattern of immunological reactivity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen.

            Dendritic cells (DCs) are crucial for mounting allergic airway inflammation, but it is unclear which subset of DCs performs this task. By using CD64 and MAR-1 staining, we reliably separated CD11b(+) monocyte-derived DCs (moDCs) from conventional DCs (cDCs) and studied antigen uptake, migration, and presentation assays of lung and lymph node (LN) DCs in response to inhaled house dust mite (HDM). Mainly CD11b(+) cDCs but not CD103(+) cDCs induced T helper 2 (Th2) cell immunity in HDM-specific T cells in vitro and asthma in vivo. Studies in Flt3l(-/-) mice, lacking all cDCs, revealed that moDCs were also sufficient to induce Th2 cell-mediated immunity but only when high-dose HDM was given. The main function of moDCs was the production of proinflammatory chemokines and allergen presentation in the lung during challenge. Thus, we have identified migratory CD11b(+) cDCs as the principal subset inducing Th2 cell-mediated immunity in the LN, whereas moDCs orchestrate allergic inflammation in the lung. Copyright © 2013 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of viral respiratory infections in asthma and asthma exacerbations

              Summary Viral respiratory tract infections are common and usually selflimited illnesses. For patients at risk of asthma, or with existing asthma, viral respiratory tract infections can have a profound effect on the expression of disease or loss of control. New evidence has shown that wheezing episodes early in life due to human rhinoviruses are a major risk factor for the later diagnosis of asthma at age 6 years. For those with existing asthma, exacerbations are a major cause of morbidity, can need acute care, and can, albeit rarely, result in death. Viral respiratory tract infections, predominantly those caused by human rhinoviruses, are associated with asthma exacerbations. There is also evidence that deficiencies in antiviral activity and the integrity of the airway epithelial barrier could make individuals with asthma more likely to have severe viral respiratory infections of the lower airway, and thus increase the risk of exacerbation. In view of the effect of respiratory viruses on many aspects of asthma, efforts to understand the mechanisms and risk factors by which these airway infections cause changes in airway pathophysiology are a first step towards improved treatment.
                Bookmark

                Author and article information

                Journal
                100941354
                Nat Immunol
                Nat. Immunol.
                Nature immunology
                1529-2908
                1529-2916
                16 August 2019
                07 October 2019
                November 2019
                07 April 2020
                : 20
                : 11
                : 1444-1455
                Affiliations
                [1 ]Laboratory of Cellular and Molecular Immunology
                [2 ]Laboratory of Immunophysiology
                [3 ]Faculty of Veterinary Medicine, Liege University, Liege, Belgium
                [4 ]Laboratory of Tumor and Development Biology, GIGA Institute, Liege University, Liege, Belgium
                [5 ]Airway Disease Section, National Heart and Lung Institute (NHLI), Imperial College London, London, UK
                [6 ]Medical Research Council (MRC) and Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK
                [7 ]Imperial College Healthcare NHS Trust, London, UK
                [8 ]WELBIO, Walloon Excellence in Life Sciences and Biotechnology, Wallonia, Belgium
                Author notes
                Corresponding authors: Thomas Marichal, Laboratory of Immunophysiology, GIGA Institute, Liege University, Quartier Hôpital, B34 Avenue de l'Hôpital 11, 4000 Liege, Belgium, t.marichal@ 123456uliege.be ; Fabrice Bureau, Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liege University, Quartier Hôpital, B34 Avenue de l'Hôpital 11, 4000 Liege, Belgium, fabrice.bureau@ 123456uliege.be
                [9]

                These authors contributed equally to this work and are co-first authors.

                [10]

                These authors contributed equally to this work and are co-last authors.

                Article
                EMS84087
                10.1038/s41590-019-0496-9
                6859073
                31591573
                e535d11d-832d-4260-bdda-a3c89fe4d2ab

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Immunology
                Immunology

                Comments

                Comment on this article